Yatsen Global expects total net revenue for the first quarter of 2026 to increase by approximately 15% to 30% year-on-year.
Yatsen Global’s Third Quarter Net Revenue Meets Expectations, Stock Price Soars by 12%.
Yatsen BioTech will be held by COSMAX with a 51% stake and Yatsen Global with a 49% stake.